Boyer David W. sold NBIX
February 6, 2024 · Form 4 insider transaction
Boyer David W. sold 216 shares of Neurocrine Biosciences, Inc. at $141.96 per share, a transaction worth $30.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
216
Price
$141.96
Total value
$30.7K
InsiderBoyer David W.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 6, 2024
Filing dateFebruary 8, 2024
Shares owned after4,894
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.